MedPath

COLESTIPOL HYDROCHLORIDE

Colestipol Hydrochloride Tablets USP

Approved
Approval ID

3d380b5e-e346-4a47-ac95-faa37c6f2a51

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 26, 2023

Manufacturers
FDA

ANI Pharmaceuticals, Inc.

DUNS: 145588013

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

COLESTIPOL HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62559-395
Application NumberANDA216517
Product Classification
M
Marketing Category
C73584
G
Generic Name
COLESTIPOL HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateApril 26, 2023
FDA Product Classification

INGREDIENTS (9)

COLESTIPOL HYDROCHLORIDEActive
Quantity: 1 g in 1 1
Code: X7D10K905G
Classification: ACTIB
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
MICROCRYSTALLINE CELLULOSE 105Inactive
Code: KO5GYV0DCB
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLACEFATEInactive
Code: F2O5O2OI9F
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4
Classification: IACT
HYPROMELLOSE 2910 (15 MPA.S)Inactive
Code: 36SFW2JZ0W
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.